ERC Proof of concept 2022 "Therapeutic innovation for cholangiocarcinoma

For the third time in five years, Professor Thomas Baumert has been awarded a prestigious ERC Proof of Concept Grant.

In February 2022, the ERC PoC-CANDY was awarded to Professor Thomas Baumert by the European Union. This award will contribute to the development of new therapeutic approaches for cholangiocarcinoma, a rare and deadly cancer, by Professor Thomas Baumert and his team.

For more information, please visit: